Browse through our

Recent Posts

Potential of Digital therapeutics and increasing CVDs

Business Consultant, Pharma Consultant, Snippets

The 21st century has been a remarkable century for humankind, as a lot of innovation, research and...

Read More

Thyroid awareness month

Infographics

January month is the Thyroid awareness month, and it is a great way to comprehend the treatment,...

Read More

Thyroid eye disease market: New therapies enter the TED market

Articles, Business Consultant, Pharma Consultant

The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and...

Read More

Tepezza receives approval; a new way to treat Alzheimer’s; and a new anti-obesity molecule

Business Consultant, Pharma Consultant, Pharma news

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug...

Read More
Have a glance at our

Featured Posts

Thyroid awareness month

Infographics

January month is the Thyroid awareness month, and it is a great way to comprehend the treatment, prevention, and causes of thyroid-related diseases and cancer for the people who are affected.One ...

Read More

Thyroid eye disease market: New therapies enter the TED market

Articles, Business Consultant, Pharma Consultant

The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare ...

Read More

Tepezza receives approval; a new way to treat Alzheimer’s; and a new anti-obesity molecule

Business Consultant, Pharma Consultant, Pharma news

Horizon Therapeutics has become the first company to receive the regulatory approval of its ...

Read More

Sign Up to access to our Newsletters.

Explore the untraversed paths through our deep insights into changing scenario of Pharma and
Biotech industry.

Our analytical perspectives on the issues that matter most in Pharma Space

Editor's pick

Thyroid eye disease market: New therapies enter the TED market

Articles, Business Consultant, Pharma Consultant

The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and...

Read More

Tepezza receives approval; a new way to treat Alzheimer’s; and a new anti-obesity molecule

Business Consultant, Pharma Consultant, Pharma news

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug...

Read More

Polypills: Can they offer a potential approach to treat CVDs?

Business Consultant, Pharma Consultant, Snippets

Cardiovascular disease (CVD), such as heart attack and stroke, is a leading cause of deaths and...

Read More

Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

Business Consultant, News, Pharma Consultant

The US FDA has recently granted Orphan Drug Designation to AstraZeneca’s Imfinzi (durvalumab) and...

Read More

Discover new pharma market trends and stay up-to-date.

In order to strive in this ever-changing pharma market, innovation has become a vitally important aspect to grow in the industry.

(Visited 662 times, 11 visits today)
Close